#CBC: “Tentative plea deal reached for Winnipeg-based pharmacy accused of selling counterfeit cancer drugs – Manitoba”


A tentative plea agreement has been reached that would see a Winnipeg-based online pharmacy and two affiliated businesses fined millions of dollars for selling misbranded and counterfeit drugs in the United States.

The agreement, which still has to be approved by a U.S. district court in Montana, would see Canada Drugs and two subsidiaries plead guilty, pay a $5 million US fine and forfeit $29 million US.

A separate plea agreement for the company’s president, Kris Thorkelson, would see Thorkelson pay a $250,000 fine and serve six months of house arrest followed by four and a half years of probation.

The deals would also require the company to surrender its domain names and stop any distribution of unapproved or misbranded drugs in the U.S.

Canada Drugs was charged with selling counterfeit cancer drugs online over a three-year period ending in 2012.

Four Winnipeg men were also charged along with Thorkelson: CanadaDrugs.com CFO Ronald Sigurdson; Thomas Haughton, president of two CanadaDrugs subsidiaries operating in Barbados and the U.K.; Darren Chalus, director of clinical sales for CanadaDrugs; and Troy Nakamura, clinical manager for CanadaDrugs.

An extradition hearing for the four men was scheduled for May of next year.

The U.S. Food and Drug Administration would not comment on the matter while it is still before the courts, and calls to Canada Drugs, Thorkelson and the company’s lawyer were not returned.

Note: “Previously Published on: 15 December 2017 | 9:11 pm, as ‘Tentative plea deal reached for Winnipeg-based pharmacy accused of selling counterfeit cancer drugs – Manitoba’ on CBC RADIO-CANADA. Here is a source link for the Article’s Image(s) and Content”.

CBC Radio-Canada

Copyright © CBC Radio-Canada. All rights reserved. Distributed by the PressOcean Media. Contact the copyright holder directly for corrections or for permission to republish or make other authorized use of this material... Articles and commentaries that identify the PressOcean as the publisher are produced or commissioned by the PressOcean Media. To address comments or complaints, please Contact us.


No comments!

There are no comments yet, but you can be first to comment this article.

Leave reply

Only registered users can comment.